Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
National Institute on Drug Abuse (NIDA) |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00218387 |
Cocaine addiction is a serious health problem with no available medical treatment for preventing relapse. Modafinil, a medication that enhances mood, increases energy, and improves concentration, may be useful in preventing relapse among individuals with cocaine addiction. This study will evaluate the effectiveness of modafinil, in combination with cognitive behavior therapy (CBT), to prevent drug relapse among cocaine addicts.
Condition | Intervention | Phase |
---|---|---|
Cocaine Dependence |
Drug: Modafinil Drug: Matching Placebo |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | CBT and Modafinil for Cocaine Addiction |
Estimated Enrollment: | 309 |
Study Start Date: | April 2004 |
Estimated Study Completion Date: | October 2010 |
Estimated Primary Completion Date: | April 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
200mg Modafinil
|
Drug: Modafinil
200mg Modafinil
|
2: Experimental
400mg Modafinil
|
Drug: Modafinil
400mg Modafinil
|
3: Placebo Comparator
Matching Placebo
|
Drug: Matching Placebo
Matching Placebo
|
The development of a medication to treat cocaine addiction specifically by lessening withdrawal symptoms has been a primary focus of research. Common cocaine withdrawal symptoms include depression, lack of energy, and poor concentration. Modafinil, a central nervous system stimulant, is a medication that can speed up physical and mental processes in the brain. It is currently used to treat narcolepsy, a condition that causes excessive sleepiness.
Modafinil enhances mood, increases energy, and improves concentration in people with narcolepsy. Modafinil may also cause the same effects in individuals addicted to cocaine, thereby countering the symptoms of cocaine withdrawal. The purpose of this study is to compare the effectiveness of modafinil plus CBT versus placebo plus CBT for treating cocaine dependence.
A 2-week screening period will be followed by an 8-week treatment phase. Participants will be randomly assigned to receive either 200 mg of modafinil, 400 mg of modafinil, or placebo on a daily basis for the 8 weeks of treatment. During this time, participants will be asked to report the number of days that they use and do not use cocaine. This will be confirmed three times a week with urine tests. Mood, level of daytime sleepiness, and symptoms of cocaine withdrawal and cocaine "high" will be evaluated. Compliance with study medication will be assessed with urine and blood tests.
Medication side effects will be monitored through physical examinations, routine lab tests, ECGs, and self-reports. Follow-up evaluations will occur 4 and 8 weeks following the end of treatment.
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion criteria:
Contact: Kristi Huebner, MPH | (843)792-1901 | huebnerk@musc.edu |
United States, South Carolina | |
Medical University of South Carolina | Recruiting |
Charleston, South Carolina, United States, 29425 | |
Contact: Kristi Huebner, MPH 843-792-1901 huebnerk@musc.edu |
Principal Investigator: | Robert Malcolm, MD | Medical University of South Carolina |
Responsible Party: | Medical University of South Carolina ( Robert Malcolm, MD ) |
Study ID Numbers: | NIDA-16368-1, R01-16368-1, DPMC |
Study First Received: | September 16, 2005 |
Last Updated: | January 6, 2009 |
ClinicalTrials.gov Identifier: | NCT00218387 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Cocaine-Related Disorders Behavior, Addictive Mental Disorders Substance-Related Disorders Disorders of Environmental Origin |
Central Nervous System Stimulants Cocaine Neuroprotective Agents Modafinil |
Cocaine-Related Disorders Mental Disorders Therapeutic Uses Physiological Effects of Drugs Substance-Related Disorders Disorders of Environmental Origin |
Central Nervous System Stimulants Protective Agents Neuroprotective Agents Central Nervous System Agents Pharmacologic Actions Modafinil |